Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Hereditary spastic paraplegia and ALS: similarities in nervous system lesions

Published on: 01/04/2016 Reading time: 1 min
image

Hereditary spastic paraplegias are a heterogeneous group of pathologies and share clinical similarities with other neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).

For the first time, Khalid H. El Hachimi and his collaborators in Alexis Brice's team, showed neuropathological similarities (at the level of the nervous system lesions) between type 11 spastic paraplegia and ALS. This discovery will enable clinicians to make an accurate and early diagnosis facing an " atypical " ALS, via research of a mutation in SPG11 gene. On the other hand, the understanding of the mechanisms involved in these pathologies paves the way for the development of new targeted therapeutics.

Hereditary spastic paraplegias are a heterogeneous group of diseases on clinical, genetic, and neuropathological levels. The most common inherited autosomal recessive form, is caused by a mutation in SPG11 gene. Clinical signs gradually settle down and are characterised by very debilitating walking disorders due to lower limbs stiffness or spasticity. This clinical presentation can be complicated by various symptoms shared with other neurological diseases such as amyotrophic lateral sclerosis, neuropathies or cerebellar ataxias. From a physiopathological point of view, this disease is characterised by degeneration of the cortico-spinal beam (neurons are located in the motor cortex and their axons are projected onto the spinal cord) controlling voluntary motor skills.

For the first time, Khalid H. El Hachimi and his collaborators in Alexis Brice's team, showed neuropathological similarities (at the level of the nervous system lesions) between type 11 spastic paraplegia and ALS. Through the post-mortem study on patients' brains, researchers have observed lesions (ubiquitin and P62) at the level of the spinal cord and medulla oblongata similar to those found in ALS. These specific inclusions in motor neurons are also associated to an accumulation of lipidic products. The protein encoded by SPG11 gene, called spatacsin is involved in vesicular and axonal transport, calcium homeostasis regulation and in lysosome recycling. The loss of function of spatacsin would lead to a lysosome recycling defect and an intra-neuronal accumulation of non-degraded products, which could be associated to neuronal death.

These studies illustrate neuropathological similarities between spastic paraplegias and ALS, and highlight the pathophysiological continuum of motor neuron degeneration. These results also contribute to a better understanding of lysosomal dysregulations and could open new paths for the development of therapeutic solutions.

Reference : Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions.

Sources

https://academic.oup.com/brain/article/139/6/1723/1753693

Our news on the subject

Une personne écrit sur un tableau
Looking back at the “Brain to Market” Summer School 2024 dedicated to motor neurone disease
From September 9 to 13, the Open Brain School, the education center at Paris Brain Institute, organized the 10th edition of its flagship training program in neuroscience and entrepreneurship—dedicated to fostering innovation. This event brought the...
10.07.2024 Teaching & training
Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
See all our news